Kontakt 2018, 20(2):e134-e143 | DOI: 10.1016/j.kontakt.2018.05.001

Remote monitoring of patients with implantable cardioverter-defibrillators: Perception of the impact of monitoring and selected determinants of quality of lifeNursing - Original article

Iva Šafaříková^a,b,*, Alan Bulava^a,b,c

^a Jihočeská univerzita v Českých Budějovicích, Zdravotně sociální fakulta, České Budějovice, Česká republika

^b Nemocnice České Budějovice, a. s., oddělení kardiologie, Kardiocentrum, České Budějovice, Česká republika

^c Univerzita Palackého v Olomouci, Lékařská fakulta, Olomouc, Česká republika

The number of patients with implantable cardioverter-defibrillators (ICD) has been continuously rising. Telemonitoring care (Home Monitoring^TM - HM) has been increasingly used during the monitoring of these patients.

Methods: 150 patients with ICDs who were monitored using the HM system (HM+), and 150 patients with ICDs who were monitored using standard outpatient check-ups (HM-) were included. A questionnaire, which focused on the quality of life (QoL) (EQ5D-3L), level of anxiety and depression (HADS), and a custom questionnaire examining the subjective approach of patients to the HM system and telecare workflow, was sent out to all patients.

Results: The method of ICD monitoring did not directly influence the QoL (p = NS). A non-significant trend towards better QoL in HM+ compared to HM- patients was recorded. It was based on total QoL scores (68.6 ± 19 vs. 64.6 ± 16.5, p = 0.09). Regarding anxiety and depression, statistical testing also failed to find any difference between HM+ and HM- patients. The most striking difference between HM+ and HM- patients was recorded in the preference for the type of monitoring. 54.9% of HM- patients were interested in remote monitoring, 45.1% said they preferred outpatient check-ups, and only 6.7% (p < 0.0001) of HM+ patients were interested in switching to outpatient check-ups from remote monitoring. HM+ patients were more inclined to use remote ICD monitoring (p = 0.007) and had a positive approach toward the telecare system (p = 0.034).

Conclusion: The method of device monitoring does not significantly affect QoL in patients with ICDs, nor does it affect levels of anxiety and depression. Generally, patients with ICDs monitored using the HM system were very satisfied with telecare and would prefer not to lose remote ICD monitoring.

Keywords: Telemedicine; Implantable cardioverter-defibrillators; Home Monitoring; Quality of life

Received: December 20, 2017; Revised: March 17, 2018; Accepted: May 4, 2018; Published: June 26, 2018  Show citation